2022 / 06

Next Paper
DOI: 10.24075/brsmu.2022.070

ORIGINAL RESEARCH

Knockout of mutant TP53 in the HaCaT cells enhances their migratory activity

Kozhin PM, Romashin DD, Rusanov AL, Luzgina NG
About authors

Orekhovich Research Institute of Biomedical Chemistry, Moscow, Russia

Correspondence should be addressed: Alexander L. Rusanov
Pogodinskaya, 10, str. 8, Moscow, 119121, Russia; moc.liamg@vonasur.l.rednaxela

About paper

Funding: the study was carried out as part of the Program for fundamental research in the Russian Federation for the long-term period (2021–2030) (№ 122022800481-0).

Author contribution: Luzgina NG, Rusanov AL — study concept; Romashin DD, Kozhin PM, Luzgina NG, Rusanov AL — study design and literature review; Romashin DD, Kozhin PM — study planning and execution; Kozhin PM, Romashin DD, Luzgina NG, Rusanov AL — data analysis and interpretation; Kozhin PM, Romashin DD — manuscript writing; Kozhin PM, Romashin DD, Luzgina NG, Rusanov AL — manuscript editing.

Compliance with ethical standards: the study was carried out in accordance with the Declaration of Helsinki of the World Medical Association and all its revisions.

Received: 2022-12-12 Accepted: 2022-12-24 Published online: 2022-12-30
|
  1. Petushkova NA, Rusanov AL, Pyatnitskiy MA, et al. Proteomic characterization of HaCaT keratinocytes provides new insights into changes associated with SDS exposure. Biomed Dermatol. 2020; 4 (1): 4. DOI:10.1186/s41702-019-0054-y.
  2. Rusanov AL, Nakhod KV, Nakhod VI, Poverennaya EV, Petushkova NA, Luzgina NG. Changes in the Proteome of HaCaT Keratinocytes Induced by Cytotoxic Substance Triton X-100. Bull Exp Biol Med. 2017; 163 (5): 620–22. DOI: 10.1007/s10517-017-3863-2.
  3. Smits JPH, Niehues H, Rikken G, et al. Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models. Sci Rep. 2017; 7 (1): 11838. DOI: 10.1038/s41598-017- 12041-y.
  4. Lehman TA, Modali R, Boukamp P, et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis. 1993; 14 (5): 833–9. DOI: 10.1093/carcin/14.5.833.
  5. Martynova E, Pozzi S, Basile V, et al. Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63. Oncotarget. 2012; 3 (2): 132–43. DOI: 10.18632/ oncotarget.447.
  6. Xu J, Reumers J, Couceiro JR, et al. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol. 2011; 7 (5): 285–95. DOI: 10.1038/nchembio.546.
  7. Cordani N, Pozzi S, Martynova E, et al. Mutant p53 subverts p63 control over KLF4 expression in keratinocytes. Oncogene. 2011; 30 (8): 922–32. DOI: 10.1038/onc.2010.474.
  8. Neilsen PM, Noll JE, Suetani RJ, et al. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget. 2011; 2 (12): 1203–17. DOI: 10.18632/oncotarget.382.
  9. Rusanov AL, Kozhin PM, Romashin DD, Karagyaur MN, Luzgina NG. Impact of р53 modulation on interactions between р53 family members during НаСаT keratinocytes differentiation. Bulletin of RSMU. 2020; (6): 58–65. DOI: 10.24075/brsmu.2020.082.
  10. Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer. J Pathol. 2011; 223 (2): 116–26. DOI: 10.1002/path.2784.
  11. Muller PAJ, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol. 2011; 192 (2): 209. DOI: 10.1083/jcb.201009059.
  12. van der Walt S, Schönberger JL, Nunez-Iglesias J, et al. scikit-image: image processing in Python. PeerJ. 2014; 2: e453. DOI: 10.7717/peerj.453.
  13. Rusanov AL, Romashin DD, Kozhin PM, et al. Impact of p53 Knockout on Protein Data Set of HaCaT Cells in Confluent and Subconfluent Conditions. Data. 2022; 7 (3). DOI: 10.3390/ data7030027.
  14. Wickham H, Averick M, Bryan J, et al. Welcome to the Tidyverse. J Open Source Softw. 2019; 4: 1686. DOI: 10.21105/joss.01686.
  15. Rusanov AL, Luzgina ED, Vakhrushev IV, Nakhod KV, Luzgina NG. A Cell Model of Human Small Intestinal Wall Based on Genetically Modified Caco-2 Cells. Bull Exp Biol Med. 2018; 166 (1): 174–7. DOI: 10.1007/s10517-018-4308-2.
  16. Sprenger A, Weber S, Zarai M, et al. Consistency of the proteome in primary human keratinocytes with respect to gender, age, and skin localization. Mol Cell Proteomics MCP. 2013; 12 (9): 2509– 21. DOI: 10.1074/mcp.M112.025478.
  17. Rousselle P, Beck K. Laminin 332 processing impacts cellular behavior. Cell Adhes Migr. 2013; 7 (1): 122–34. DOI: 10.4161/cam.23132.
  18. Natsumi A, Sugawara K, Yasumizu M, et al. Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis? J Histochem Cytochem. 2018; 66 (12): 847–62. DOI: 10.1369/0022155418782693.
  19. Huang C, Chen J. Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma. Mol Med Rep. 2021; 23 (1): 11. DOI: 10.3892/mmr.2020.11649.